Viewing Study NCT07168694

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2026-01-26 @ 7:08 AM
Study NCT ID: NCT07168694
Status: COMPLETED
Last Update Posted: 2025-09-11
First Post: 2025-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in Russia
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Secondary Progressive Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Siponimod View
None Treatment of multiple sclerosis View
None Real-world clinical data View